However, in August 2023, many patients filed claims against Novo Nordisk, the drugs manufacturer
Semaglutide (Wegovy) produced an average weight loss of 14.9% over 68 weeks in the STEP 1 trial of 1,961 adults
Reddy's Laboratories received approval to sell generic semaglutide in injectable format in Canada, having applied in February 2024
Common Side Effects of Semaglutide While semaglutide is highly effective, it can come with some side effects
Compounded GLP-1 telehealth providers can only ship to states where their partner compounding pharmacies hold non-resident pharmacy licensure, and where the prescribing provider is licensed
Some risks of using compounded semaglutide include: Unknown side effects Wrong doses Contamination Risk of drug interactions Mistakes in labeling Allergenic or expired ingredients Its best to talk to a healthcare provider before trying compounded semaglutide